Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers. [electronic resource]
Producer: 20171003Description: 316-22 p. digitalISSN:- 1557-2501
- Absorbable Implants -- adverse effects
- Aged
- Australia -- epidemiology
- Coronary Angiography -- methods
- Coronary Artery Disease -- diagnosis
- Drug-Eluting Stents -- adverse effects
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Outcome and Process Assessment, Health Care
- Percutaneous Coronary Intervention -- adverse effects
- Postoperative Complications -- classification
- Prosthesis Design
- Registries
- Tissue Scaffolds -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.